[A cyclooxygenase-2 selective inhibitor worsens respiratory function and enhances mast cell activity in ovalbumin-sensitized mice].

[1]  P. Tornero,et al.  Tolerability to nabumetone and meloxicam in patients with nonsteroidal anti-inflammatory drug intolerance. , 2007, The Journal of allergy and clinical immunology.

[2]  M. Lomask.  Further exploration of the Penh parameter. , 2006, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[3]  S. Holgate,et al.  The role of the mast cell in the pathophysiology of asthma. , 2006, The Journal of allergy and clinical immunology.

[4]  Chunli Feng,et al.  Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses. , 2006, Blood.

[5]  L. Kay,et al.  Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation , 2006, British journal of pharmacology.

[6]  M. Kowalski,et al.  Use of Nonsteroidal Anti-Inflammatory Drugs in Patients with Aspirin Hypersensitivity , 2006, Treatments in Respiratory Medicine.

[7]  C. Picado,et al.  Descubriendo el asma de origen alérgico a través del ratón. Un repaso a la patogenia de los modelos de asma alérgica en el ratón y su similitud con el asma alérgica humana , 2005 .

[8]  K. Yamagata,et al.  Augmentation of allergic inflammation in the airways of cyclooxygenase‐2‐deficient mice , 2005, Respirology.

[9]  C. Picado,et al.  [Use of the mouse to unravel allergic asthma: a review of the pathogenesis of allergic asthma in mouse models and its similarity to the condition in humans]. , 2005, Archivos de bronconeumologia.

[10]  R. Breyer,et al.  Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. , 2004, Pharmacology & therapeutics.

[11]  L. Mastalerz,et al.  Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs. , 2003, Archives of dermatology.

[12]  Maree H. Poniris,et al.  PAR-2 activation, PGE2, and COX-2 in human asthmatic and nonasthmatic airway smooth muscle cells. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[13]  M. Sanak,et al.  Deficient prostaglandin E2 production by bronchial fibroblasts of asthmatic patients, with special reference to aspirin-induced asthma. , 2003, The Journal of allergy and clinical immunology.

[14]  J. Mullol,et al.  Nuclear factor‐κB activity is down‐regulated in nasal polyps from aspirin‐sensitive asthmatics , 2003, Allergy.

[15]  J. Mullol,et al.  Cyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps. , 2002, The Journal of allergy and clinical immunology.

[16]  J. Morrow,et al.  Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice. , 2002, American journal of respiratory and critical care medicine.

[17]  E. Okuda‐Ashitaka,et al.  Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin , 2001, Neuroscience Research.

[18]  J. Pammer,et al.  In situ detection of the mast cell proteases chymase and tryptase in human lung tissue using light and electron microscopy , 2001, Histochemistry and Cell Biology.

[19]  M. Taniguchi,et al.  Possible involvement of mast‐cell activation in aspirin provocation of aspirin‐induced asthma , 2001, Allergy.

[20]  Fitzgerald Ga,et al.  Selective inhibitors of cyclooxygenase-2: a growing class of anti-inflammatory drugs. , 2001 .

[21]  G. FitzGerald,et al.  Selective inhibitors of cyclooxygenase-2: a growing class of anti-inflammatory drugs. , 2001, Molecular interventions.

[22]  B. Graham,et al.  Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice. , 2000, American journal of respiratory and critical care medicine.

[23]  I. Serizawa,et al.  An Essential Role of Mast Cells in the Development of Airway Hyperresponsiveness in a Murine Asthma Model , 2000, The Journal of Immunology.

[24]  S. Narumiya,et al.  Prostaglandin D2 as a mediator of allergic asthma. , 2000, Science.

[25]  M. Kowalski,et al.  Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients. , 2000, American journal of respiratory and critical care medicine.

[26]  D. Zeldin,et al.  Allergic lung responses are increased in prostaglandin H synthase-deficient mice. , 1999, The Journal of clinical investigation.

[27]  J. Mullol,et al.  Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. , 1999, American journal of respiratory and critical care medicine.

[28]  P. O'Byrne,et al.  Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation. , 1999, American journal of respiratory and critical care medicine.

[29]  E. Gelfand,et al.  Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. , 1997, American journal of respiratory and critical care medicine.

[30]  R. M. Refini,et al.  Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. , 1996, American journal of respiratory and critical care medicine.

[31]  P. O'Byrne,et al.  Effect of inhaled PGE2 on exercise-induced bronchoconstriction in asthmatic subjects. , 1994, American journal of respiratory and critical care medicine.

[32]  P. O'Byrne,et al.  Exercise-induced refractoriness in asthmatic subjects involves leukotriene and prostaglandin interdependent mechanisms. , 1993, The American review of respiratory disease.

[33]  S. Godfrey,et al.  The refractory period after exercise-induced asthma: its duration and relation to the severity of exercise. , 2015, The American review of respiratory disease.